Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Department of General Surgery, Peking University People’s Hospital, Beijing, China Department of Retroperitoneal Tumor Surgery ... The G2 group also displayed more aggressive molecular features and ...

Braun, an Assistant Professor of Medicine, Medical Oncology, and a Louis Goodman and Alfred Gilman Yale Scholar, at the Yale School of Medicine, as well as a member of the Center of Molecular and ...

Colon cancer develops when tumorous growths form in the large intestine. It often produces no symptoms in the early stages, but people should see a doctor if they notice persistent changes in ...

Not only is it reasonably priced, but it’s lightweight, comfortable to use, and delivers a great typing experience. With multi-connectivity options and a 36-hour battery life, you also get the ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

"Effective cancer management depends on accurate typing, sub-typing, and grading," Dr Megha Uppin ... "Brain tumour diagnoses increasingly rely on molecular genetics, requiring pathologists to adopt ...